Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Pariet submitted for ZES and pathological hypersecretory conditions in Europe

Dec. 18, 2003

Chugai launches Pegasys in Japan

Dec. 17, 2003

Phase II results for Itax confirm earlier safety and efficacy findings

Dec. 17, 2003

Compositions of lafutidine for IBD

Dec. 16, 2003

Spring Bank acquires rights to MBI-1313 for HBV from Micrologix

Dec. 15, 2003

Isatoribine biologically active in HCV patients in phase Ib trial

Dec. 10, 2003

Altana describes dual NO-donating gastric antisecretory agents

Dec. 10, 2003

Zorbtive receives FDA approval for short bowel syndrome

Dec. 5, 2003

Positive results for icatibant in treatment of refractory ascites in liver cirrhosis

Dec. 4, 2003

Celltech to regain rights to CDP-870 from Pfizer

Dec. 3, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.